Explore

Companies
Investors
Funds
Markets
Compare

Capbase

About
FAQ
Data & sources
Contribute

Compare

Crunchbase alternative
PitchBook alternative

Legal

Terms of Service
Privacy Policy
Takedown policy

ATMAN THERAPEUTICS CO. — Funding, Investors & Profile — Capbase

← All companies

Compare History

ATMAN THERAPEUTICS CO.

Private

Won a federal SBIR/STTR research award from HHS and other federal agencies.

Department of Health and Human ServicesNational Institutes of Health

DUNS: 116914366

Founded: —Source: [GOV]
Headquarters: NEW HAVEN, ConnecticutSource: [GOV]
Headcount: 5Source: [GOV]
Stage: Seed
Sector: Healthcare

$0Source: [GOV]Total raised

UndisclosedSource: [GOV]Last valuation

Overview

ATMAN THERAPEUTICS CO. has been awarded 1 US Small Business Innovation Research (SBIR/STTR) contract totalling $253,882 in 2021. These are non-dilutive federal research grants, not equity financing. The company is based in NEW HAVEN, Connecticut.

Funding rounds

1 rounds

SBIR Phase I award (HHS)GrantSep 2021Source: [GOV]
$253.9K
—post-money

Investors

No investors recorded yet for ATMAN THERAPEUTICS CO..

Add an investor

People

Leadership

MICHAEL EASTONPrincipal investigatorSince 2021Source: [GOV]

Acquisitions

ATMAN THERAPEUTICS CO. has no recorded acquisitions.

Add an acquisition

Exits

Still private — no exit on record.

Record an exit

Diversity investments

No diversity signals recorded yet for ATMAN THERAPEUTICS CO..

Add diversity data

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.